Oktoscience focuses on creating implantable neuromodulation systems and is currently developing its first device specifically for epilepsy therapy. The company is progressing on both the scientific and financial fronts to bring this solution to market. To support its research and development, Oktoscience identified an overall financing requirement of about €1.5 million. It recently secured an initial tranche of funding through the Sowefund crowdfunding platform, closing at 252 (units not specified in the article). This capital will be used to advance product development and clinical validation efforts. The firm continues to seek additional investment to complete the targeted €1.5 million raise. No operating metrics such as revenue or user numbers were disclosed in the available article excerpt.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2026